
| ROI Name | ∑ In | % In | log ratio | ∑ Out | % Out |
|---|---|---|---|---|---|
| EB | 2,048 | 86.6% | 0.71 | 3,357 | 98.2% |
| FB | 251 | 10.6% | -2.97 | 32 | 0.9% |
| BU_L | 23 | 1.0% | -2.20 | 5 | 0.1% |
| CRE_L | 20 | 0.8% | -2.00 | 5 | 0.1% |
| MB_PED_L | 12 | 0.5% | -1.00 | 6 | 0.2% |
| MB_ML_L | 6 | 0.3% | -0.26 | 5 | 0.1% |
| GA_L | 3 | 0.1% | 1.00 | 6 | 0.2% |
| AVLP_L | 1 | 0.0% | 0.00 | 1 | 0.0% |
| upstream partner | # | NT | conns ER3p_b | % In | CV |
|---|---|---|---|---|---|
| ER3p_b (L) | 3 | GABA | 156.3 | 21.6% | 0.2 |
| EL (L) | 8 | GABA | 126 | 17.4% | 0.3 |
| EL (R) | 9 | GABA | 82 | 11.3% | 0.3 |
| ER3d (R) | 15 | GABA | 80 | 11.1% | 1.5 |
| ER3p_b (R) | 2 | GABA | 68.3 | 9.5% | 0.3 |
| TuBu04 (L) | 4 | ACh | 68 | 9.4% | 0.3 |
| ER3d (L) | 12 | GABA | 62.3 | 8.6% | 1.3 |
| ExR3 (R) | 1 | DA | 17 | 2.4% | 0.0 |
| ExR3 (L) | 1 | Unk | 12.7 | 1.8% | 0.0 |
| ER3p_a (L) | 6 | GABA | 9.7 | 1.3% | 1.0 |
| ExR1 (L) | 2 | GABA | 7.3 | 1.0% | 0.2 |
| ER3m (L) | 7 | GABA | 6.7 | 0.9% | 0.5 |
| ER3p_a (R) | 5 | GABA | 4.7 | 0.6% | 0.7 |
| ER3m (R) | 7 | GABA | 4.7 | 0.6% | 0.5 |
| ExR1 (R) | 2 | Unk | 2.7 | 0.4% | 0.5 |
| ER2 (L) | 6 | GABA | 2.7 | 0.4% | 0.4 |
| EPG (R) | 3 | ACh | 1.3 | 0.2% | 0.4 |
| EPG (L) | 2 | ACh | 1.3 | 0.2% | 0.5 |
| ER3a_a,ER3a_d (L) | 3 | GABA | 1.3 | 0.2% | 0.4 |
| ER3w (R) | 2 | GABA | 1 | 0.1% | 0.3 |
| PFGs (L) | 2 | Unk | 1 | 0.1% | 0.3 |
| ER3a_b,ER3a_c (R) | 2 | GABA | 1 | 0.1% | 0.3 |
| ER3w (L) | 3 | GABA | 1 | 0.1% | 0.0 |
| ER3a_a,ER3a_d (R) | 1 | GABA | 0.7 | 0.1% | 0.0 |
| ER4d (L) | 1 | GABA | 0.7 | 0.1% | 0.0 |
| ER2 (R) | 2 | GABA | 0.7 | 0.1% | 0.0 |
| ER3a_b,ER3a_c (L) | 1 | GABA | 0.3 | 0.0% | 0.0 |
| EPGt (L) | 1 | ACh | 0.3 | 0.0% | 0.0 |
| FB4K (L) | 1 | 5-HT | 0.3 | 0.0% | 0.0 |
| CB1591 (L) | 1 | ACh | 0.3 | 0.0% | 0.0 |
| ER1 (R) | 1 | GABA | 0.3 | 0.0% | 0.0 |
| AOTU046 (R) | 1 | Unk | 0.3 | 0.0% | 0.0 |
| downstream partner | # | NT | conns ER3p_b | % Out | CV |
|---|---|---|---|---|---|
| ER3p_b (L) | 3 | GABA | 156.3 | 22.0% | 0.3 |
| ER3d (R) | 20 | GABA | 74.7 | 10.5% | 1.2 |
| EL (R) | 9 | GABA | 65.3 | 9.2% | 0.3 |
| EL (L) | 8 | GABA | 63.3 | 8.9% | 0.3 |
| EPG (L) | 24 | ACh | 62 | 8.7% | 0.5 |
| ER3d (L) | 17 | GABA | 60.7 | 8.5% | 1.4 |
| ER3p_b (R) | 2 | GABA | 59.7 | 8.4% | 0.3 |
| EPG (R) | 22 | ACh | 55 | 7.8% | 0.7 |
| ER3p_a (L) | 9 | GABA | 23.3 | 3.3% | 1.8 |
| ER3m (L) | 8 | GABA | 13.7 | 1.9% | 0.3 |
| ER3m (R) | 7 | GABA | 12.7 | 1.8% | 0.5 |
| ExR1 (L) | 2 | GABA | 11.7 | 1.6% | 0.1 |
| ER3p_a (R) | 8 | GABA | 11.3 | 1.6% | 0.8 |
| ExR1 (R) | 2 | Unk | 9 | 1.3% | 0.6 |
| ExR3 (L) | 1 | Unk | 5 | 0.7% | 0.0 |
| PFGs (L) | 3 | 5-HT | 3.7 | 0.5% | 0.1 |
| ExR3 (R) | 1 | DA | 2.7 | 0.4% | 0.0 |
| ER2 (L) | 5 | GABA | 2.7 | 0.4% | 0.5 |
| ER2 (R) | 4 | GABA | 2.3 | 0.3% | 0.7 |
| ER3a_a,ER3a_d (R) | 3 | GABA | 2 | 0.3% | 0.4 |
| ER3w (L) | 3 | GABA | 2 | 0.3% | 0.4 |
| TuBu04 (L) | 3 | ACh | 1.7 | 0.2% | 0.3 |
| ER3a_a,ER3a_d (L) | 3 | GABA | 1.3 | 0.2% | 0.4 |
| ExR7 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| ER1 (L) | 3 | GABA | 1 | 0.1% | 0.0 |
| ER3a_b,ER3a_c (R) | 1 | GABA | 1 | 0.1% | 0.0 |
| ER3w (R) | 3 | GABA | 1 | 0.1% | 0.0 |
| CB2781 (L) | 1 | Unk | 0.7 | 0.1% | 0.0 |
| CB1454 (L) | 1 | Glu | 0.3 | 0.0% | 0.0 |
| ER3a_b,ER3a_c (L) | 1 | GABA | 0.3 | 0.0% | 0.0 |
| LAL073 (L) | 1 | Glu | 0.3 | 0.0% | 0.0 |
| ER1 (R) | 1 | GABA | 0.3 | 0.0% | 0.0 |
| AOTU046 (L) | 1 | Unk | 0.3 | 0.0% | 0.0 |
| ER5 (L) | 1 | GABA | 0.3 | 0.0% | 0.0 |
| MBON02 (L) | 1 | Glu | 0.3 | 0.0% | 0.0 |
| ExR5 (R) | 1 | Glu | 0.3 | 0.0% | 0.0 |
| FB2B (R) | 1 | Unk | 0.3 | 0.0% | 0.0 |